1 2 3 4 5 6 7 8 9 10 Several hypotheses have been - - PDF document

1 2 3 4 5 6 7 8 9 10
SMART_READER_LITE
LIVE PREVIEW

1 2 3 4 5 6 7 8 9 10 Several hypotheses have been - - PDF document

1 2 3 4 5 6 7 8 9 10 Several hypotheses have been proposed for the mechanism of CFRD pathogenesis Pancreatic destruction leads to loss if islet cells, fibrosis, and amyloid deposits in islets 1 Defective CFTR activity led to


slide-1
SLIDE 1

1

slide-2
SLIDE 2

2

slide-3
SLIDE 3

3

slide-4
SLIDE 4

4

slide-5
SLIDE 5

5

slide-6
SLIDE 6

6

slide-7
SLIDE 7

7

slide-8
SLIDE 8

8

slide-9
SLIDE 9

9

slide-10
SLIDE 10

10

slide-11
SLIDE 11
  • Several hypotheses have been proposed for the mechanism of CFRD

pathogenesis – Pancreatic destruction leads to loss if islet cells, fibrosis, and amyloid deposits in islets1 – Defective CFTR activity led to insufficient depolarization and Ca2+ mobilization in response to glucose in cultured β-cells2 – β-cells synthesize large amounts of protein. Chronic accumulation of misfolded CFTR may overwhelm the β-cell proteolytic degradation pathways leading to sustained endoplasmic reticulum stress responses (unfolded protein response, endoplasmic reticulum-associated protein degradation) and β-cell apoptosis3 – A chronic inflammatory state produced by oxidative stress, ROS production,4 elevated pro-inflammatory cytokines,1 defective fat-soluble antioxidant absorption, and possibly vitamin D deficiency contribute to β- cell destruction and dysfunction and insulin resistance1,4 – Insulin sensitivity is normal in patients with CF in most studies,1,5 and in studies showing reduced insulin sensitivity, issues of study populations, methods, and interpretation may be factors5 – Insulin resistance in CF may develop because of abnormal localization of the GLUT-4 glucose transporter and/or elevated tumor necrosis factor alpha (TNF-α) levels6 References 1. Barrio R. Eur J Endocrinol. 2015;172(4):R131-R141. 2. Guo JH et al. Nat Commun. 2014;5:4420. 3. Ali BR. Med Hypotheses. 2009;72(1):55-57. 4. Galli F et al. Biochimica et Biophysica Acta. 2012;1822(5):690-713. 5. Mohan K et al. Diabet Med. 2009;26(6):582-588. 6. Hardin DS et al. Am J Physiol Endocrinol Metab. 2001;281(5):E1022-E1028.

11

slide-12
SLIDE 12

12

slide-13
SLIDE 13

13

slide-14
SLIDE 14

14

slide-15
SLIDE 15

15

slide-16
SLIDE 16

16

slide-17
SLIDE 17

17

slide-18
SLIDE 18

18

slide-19
SLIDE 19

19

slide-20
SLIDE 20

20

slide-21
SLIDE 21

21

slide-22
SLIDE 22

22

slide-23
SLIDE 23

23

slide-24
SLIDE 24

24

slide-25
SLIDE 25

25

slide-26
SLIDE 26

26

slide-27
SLIDE 27

27

slide-28
SLIDE 28

28

slide-29
SLIDE 29
  • Normal: Lumen of the pancreatic duct with balanced fluid volume and

pH1

  • CF: Pancreatic ducts are obstructed with viscous secretions, leading

to inability to secrete digestive enzymes into the gut2,3 References

  • 1. Pandol SJ. The Exocrine Pancreas. San Rafael (CA): Morgan &

Claypool Life Sciences; 2010.

  • 2. Wilschanski M et al. Gut. 2007;56(8):1153-1163.
  • 3. Derichs N. Eur Respir Rev. 2013;22(127):58-65.

29

slide-30
SLIDE 30

30

slide-31
SLIDE 31

31

slide-32
SLIDE 32

32

slide-33
SLIDE 33

33

slide-34
SLIDE 34

34

slide-35
SLIDE 35

35

slide-36
SLIDE 36

36

slide-37
SLIDE 37

37

slide-38
SLIDE 38

38

slide-39
SLIDE 39

39

slide-40
SLIDE 40

40

slide-41
SLIDE 41
  • PAP is proposed as a less costly alternative to the DNA testing or IRT

retesting after the initial elevated IRT test results in newborns1,2

  • Blood from neonatal samples (pinpricks/bloodspots) are analyzed

using ELISA method2

  • According to one proposed screening strategy (France), all newborns

are tested for IRT. Newborns with IRT >50 ng/mL are tested for PAP. Those with PAP >1.8 ng/mL and those with PAP >1.0 ng/mL and IRT > 100 ng/mL are recalled for sweat testing2 References

  • 1. Sarles J et al. Arch Dis Child Fetal Neonatal Ed. 1999;80(2):F118-

F122.

  • 2. Sarles J et al. J Pediatr. 2005;147(3):302-305.

41

slide-42
SLIDE 42
  • Wireless motility capsule system

– Measures pH and transit time – Use of pH capsule devise is limited in young children and infants due to its size Reference Bodewes FA et al. J Cyst Fibros. 2015;14(2):169-177. 42

slide-43
SLIDE 43

43

slide-44
SLIDE 44

44

slide-45
SLIDE 45

45

slide-46
SLIDE 46

46

slide-47
SLIDE 47

47

slide-48
SLIDE 48

48

slide-49
SLIDE 49

49

slide-50
SLIDE 50

50

slide-51
SLIDE 51

51

slide-52
SLIDE 52

52

slide-53
SLIDE 53

53